Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Triple Negative Metastatic Breast Cancer
NCT00827567Phase 2Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Apr 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in triple-negative breast cancer (TNBC), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Apr 2009; status: terminated.
02
Drugs
everolimus
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT00827567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827567.